To download the full report, click here.

This chart pack provides facts and figures about the promise of personalized medicine in delivering the right treatment to the right patient at the right dose the first time through the use of molecular biomarker tests and targeted therapies.

Data and information found in this publication were drawn from a wide range of sources, including government agency reports, peer?reviewed journals, and PhRMA’s own research and analysis. PhRMA hopes this publication provides useful context for discussions about the value of personalized medicine.